IHS Chemical Week

Archives :: Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Displaying 241 - 260 of 419 stories.
January 14, 2008
Hikal Ltd. (Mumbai), a manufacturer of active pharmaceutical ingredients (API) and intermediates, says it has signed a long-term agreement to contract manufacture and supply APIs for...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Hikal-to-Supply-APIs-for-Pfizer-in-Bangalore_9773.html
January 4, 2008
Process services firm PRWT Services (Philadelphia, PA), a company with no experience of running pharmaceutical manufacturing plants, says it has bought Merck &...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Merck-and-Co-Sells-U-S-Pharma-Facility-to-Sector-Entrant_9601.html
December 14, 2007
DSM business unit DSM Pharma Chemicals says it has entered into an agreement with privately owned fine chemicals firm IEP (Wiesbaden, Germany) to facilitate the fast scale-up of chiral...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/DSM-Collaborates-with-IEP-to-Supply-Chiral-Alcohols_9421.html
December 10, 2007
The U.K.’s Medicines and Healthcare Products Regulatory Agency (MHRA; London), a government body, has unveiled a three-year program to combat the sale of counterfeit drugs. The...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/U-K-Unveils-Program-Against-Counterfeit-Drugs_9308.html
December 10, 2007
Pfizer says it plans to outsource much more of its manufacturing to Asian countries, mainly India and China, to cut costs. The company is also planning to expand its R&D investment...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Pfizer-Outsources-More-to-Asia_9309.html
December 10, 2007
Contract fine chemicals manufacturer Dottikon Exclusive Synthesis (Dottikon, Switzerland) says that its net income decreased 2.1%, to $5.5 million, in its fiscal first half, ended...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Cost-Pressure-Affects-Dottikons-Half-Year-Results_9310.html
December 3, 2007
  The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA; London) has unveiled a new three-year program to combat the sale of counterfeit drugs. The program...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/U-K-Unveils-Anti-counterfeit-Drugs-Program_9194.html
November 30, 2007
Cambridge Major Laboratories (Germantown, WI), a fine chemicals contract manufacturer, says it has acquired active pharmaceutical ingredients (API) development services company...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Cambridge-Major-Buys-European-Development-Services-Firm_9171.html
November 30, 2007
A previously disclosed study on the scale of the release of harmful effluents from a wastewater treatment facility in southern India could lead to greater environmental regulations on...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Backlash-in-the-Cards-from-Indian-Plant-Effluent-Study_9172.html
November 30, 2007
Pharmaceutical companies Strides Arcolab (Bangalore, India) and Aspen (Durban, South Africa) say they have agreed on a partnership that includes asset swaps. Aspen will buy 50% of...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Strides-Arcolab-South-African-Firm-Agree-on-Assets-Swap_9173.html
November 22, 2007
Pharmaceutical company Strides Arcolab (Bangalore, India) and pharmaceuticals firm Aspen (Durban, South Africa) say they have agreed a new partnership that involves swapping assets...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Pharmaceuticals-Strides-Arcolab-and-South-African-Firm-Agree-Assets-Swap_9055.html
November 20, 2007
Glenmark Pharmaceuticals (Mumbai) says it plans to hive off its generic drugs and active pharmaceutical ingredient (API) businesses to create a new, wholly owned subsidiary, Glenmark...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Indian-Pharma-Firm-to-Spin-off-Generics-and-Ingredients_8971.html
November 20, 2007
The market for biomarkers, a sector with applications in drug discovery, clinical trials, and molecular diagnostics, is growing at a CAGR of 18% and will be worth $5.6 billion in...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Biomarkers-Sector-Slated-for-Rapid-Growth_8972.html
November 20, 2007
Cambrex says it will close its North Brunswick, NJ technical center by year-end, and consolidate its U.S. R&D activities and small-scale active pharmaceutical ingredient production...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Cambrex-Closes-New-Jersey-Site_8973.html
November 20, 2007
Merck & Co. agreed earlier this month to pay a total of $4.85 billion to 47,000 groups of plaintiffs to settle a class-action lawsuit related to Vioxx, Merck’s former...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Merck-and-Co-to-Settle-Vioxx-Claims_8975.html
November 16, 2007
  Fine chemicals contract manufacturer Cambridge Major Laboratories (Germantown, WI) says it has acquired active pharmaceutical ingredients (API) development services company...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Fine-Chemicals-Cambridge-Major-Buys-ChemShop_8993.html
November 12, 2007
The global market for biomarkers, a field that includes biomarker discovery, clinical trials and molecular diagnostics, is growing at an average annual growth rate (CAGR) of 18% and...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Biotechnology-Biomarkers-Market-Slated-for-Rapid-Growth_8854.html
November 9, 2007
Dowpharma, Dow Chemical’s business unit that offers services and products to the pharmaceuticals sector, is starting to enjoy commercial success on several fronts for its Pfenex...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Dowpharma-is-Boosted-by-Take-Up-of-Pfenex-Platform_8816.html
November 9, 2007
Cambrex reported a 30% hike in third-quarter operating profits, to $3.5 million, on sales up 2.3%, to $54.7 million. The figures relate solely to ongoing businesses. Cambrex sold its...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Cambrexs-Third-Quarter-Profits-Rise_8817.html
November 9, 2007
Novozymes says it has agreed to acquire Philom Bios (Saskatoon, SK), a manufacturer of proprietary microbial inoculants for the agricultural industry, for approximately C$25.6 million...
http://www.chemweek.com/sections/pharma_and_fine_chemicals/Novozymes-to-buy-Canadian-Firm_8818.html
Pages: « Previous  4 5 6 7 8 9 10 11 12 [13] 14 15 16 17 18 19 20 21 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa